Virupaksha Organics Ltd. has emerged as a leader in the pharmaceutical industry, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs). Founded in 2003, the company has built a reputation for innovation, quality, and sustainability. Under the dynamic leadership of Mr. Chandra Mouliswar Reddy Gangavaram, Virupaksha has grown its operations significantly, with state-of-the-art manufacturing facilities in Telangana, India.
The company’s facilities in Kazipally and Pashamylaram are certified by international and national regulatory bodies, including ISO 9001, ISO 14001, ISO 45001, ISO 50001, and GMP standards, ensuring that Virupaksha meets the highest levels of quality and safety in its production processes. These certifications highlight the company’s commitment to environmental sustainability, occupational safety, and best industry practices.
Virupaksha Organics is committed to excellence, innovation, and customer satisfaction, with a focus on developing sustainable solutions for the pharmaceutical industry. The company’s products are trusted by major pharmaceutical firms globally, as it continues to make strides towards becoming a research-driven organization. With a forward-thinking management team and a clear vision for the future, Virupaksha Organics is poised for rapid growth and continues to play a key role in advancing global healthcare.
As part of its corporate social responsibility (CSR), Virupaksha has initiated numerous welfare programs aimed at uplifting local communities and supporting environmental conservation, reinforcing its reputation as a responsible corporate citizen.
With continuous advancements and strategic partnerships, Virupaksha Organics Ltd. is well-positioned to expand its global footprint and contribute to the evolving pharmaceutical landscape.
Other Latest News
- Lunch Wrap: ASX takes a beating again as copper stocks get hammered Stockhead It was hammer(ed) time for copper stocks on Friday morning. Pic: Getty Images ASX smashed as oil brings rate fears back Copper belted and the big miners go with it GQG loses more FUM as Alkane’s boss sells shares The S&P/ASX 200 was copping a …
- Rogers uses RNC midterm platform to attack El-Sayed as Dems push back against Islamophobic rhetoric Michigan Advance The campaign of Michigan Republican U.S. Senate nominee Mike Rogers had a national audience on Thursday night as he spoke at the party’s midterm convention — a platform he used to level attacks against his Democratic opponent, Abdul El-Sayed. Much of …
- RFK Jr. eviscerates Democrats as 'insane' party that 'obliterated' the Bill of Rights The Blaze To raucous applause, Robert F. Kennedy Jr. told his story about how he became a member of the GOP. At the Republican Midterm Convention on Thursday night, Kennedy launched into a monumental speech about how Democrats turned their backs on Americans and …
- Why Is Little Green Pharma (ASX:LGP) Leaning on Europe? Kalkine Media Highlights European and United Kingdom sales moved ahead of the Australian revenue base. A court-approved scheme folded Victorian producer Cannatrek into the group. Australian regulators are examining reform of the medicinal cannabis access pathway. Little …
- Republicans' midterm promise is more populism, and more cash Semafor DALLAS – Republicans arrived at their first midterm convention ready to sell their wins for “working class” Americans, including hundreds of billions of dollars for tax cuts, refunds, and savings accounts.They left it ready to spend another trillion …
- Heavy Medicine Imports Expose Ghana's Pharmaceutical Industr... Modern Ghana Ghana's heavy dependence on imported medicines is leaving the country's pharmaceutical industry exposed to external shocks, while denying the economy significant opportunities to expand domestic manufacturing, create jobs, and retain greater value …
- Already up 137% in 1 year still JM Financial sees more upside in this stock | Check target price, shareholding pattern Mint Speciality chemical stock, Acutaas Chemicals, has given stellar rewards to its investors, and it may not be done yet. Brokerage firm JM Financial sees further upside in the stock from the current levels. On Thursday, 10 September, Acutaas Chemicals share …
- Blackstone to Acquire Flow Control Holdings, a Leader in Highly Engineered Data Center Liquid Cooling Components Investing News Network Blackstone (NYSE: BX) announced today that private equity funds affiliated with Blackstone Capital Partners and Blackstone Energy Transition Partners (collectively "Blackstone") have entered into a definitive agreement to acquire Flow Control …
- STAT+: The gifts from pharma companies that keep on giving STAT - Massachusetts For years, drugmakers have offered free meals, samples, gifts, and speaking fees to physicians, a widely studied issue due to concerns such largesse may unduly influence prescribing habits. But to what extent have interactions between doctors and …
- Why two promising heart drugs flopped and what’s next STAT - Massachusetts Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech …
- India and Russia targeting $50 bn in investments – Indian trade minister The Press United Piyush Goyal says 40 projects across areas such as advanced manufacturing, railways, and emerging technology are now live The India-Russia priority investment tracking mechanism is actively monitoring 40 projects across advanced manufacturing, energy, …
- Vice President JD Vance and President Donald Trump deliver keynote address on final day of Republican midterm convention in Dallas, Texas ABC 30 - California DALLAS, Texas -- Republicans have gathered in Dallas for the closing day of the party’s midterm convention that aims to highlight President Donald Trump ’s influence and boost enthusiasm among GOP voters ahead of November’s midterm election. Speakers at …
- Burning Rock Q2 Revenue Falls 9%; In-Hospital Business Posts Growth RTTNews Burning Rock Biotech Limited (BNR), a precision oncology company focused on next-generation sequencing (NGS) technology, reported financial results for the second quarter of 2026 and provided updates on its therapy selection and minimal residual disease ( …
- COSCIENS ACQUIRES NUALTIS CORP. EIN Presswire TORONTO, ONTARIO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) is pleased to announce the acquisition of Nualtis Corp. (“Nualtis”), a Montreal-based specialty pharmaceutical technology …
- Donald Trump had no interest in watching the horrible NFL opener, ESPN’s Taylor McGregor is a star & Danica! KLIN News Talk - Nebraska Super Bowl champion Joe Theismann previews the highly anticipated Super Bowl during an appearance on ‘Varney & Co.’ 'Nightcaps' is a daily column that catches you up on the biggest sports, news and culture stories you may have missed while …
- <![CDATA[Artisan Partners’ Director Calls for Novartis Board Shake-Up ]]> Pharmaceutical Executive A major shareholder in Novartis calls for a shake-up of the Swiss drugmaker's board to improve corporate governance, after the company's shares suffered a record fall this week following back-to-back trial setbacks. David Samra, managing director …
- Big Pharma Setbacks Create a New Wave of Rebound Plays EIN Presswire DENVER, Sept. 10, 2026 (GLOBE NEWSWIRE) -- The biotech tape delivered a brutal reminder of one of the sector’s oldest rules: even a fundamentally strong company can get caught in the crossfire when a major drugmaker suffers a pipeline setback. Yesterday …
- CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight EIN Presswire New York, USA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight The CAR T-cell therapy for NHL clinical trial analysis report delivers …
- Retension Pharmaceuticals Appoints LeAnne Bloedon, M.S., RD, as EVP of Clinical Development and Operations, and Kevin Schutz, PharmD, as VP Regulatory Affairs The Barre-Montpelier Times Argus - Vermont FALLS CHURCH, Va.--(BUSINESS WIRE)--Sep 10, 2026-- Retension Pharmaceuticals, Inc. (“Retension” or the “Company”), a clinical-stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular …
- Frazier Life Sciences nets $1.1B in long-running fund aimed at small, midsize biotechs Fierce Biotech Frazier Life Sciences (FLS) has stacked up another sizable biotech-focused capital commitment, netting more than $1.1 billion for its long-running public fund. The Palo Alto-based firm launched the fund back in 2021 and has now raised $2.8 billion. The …
- Top 10 Contract Development and Manufacturing Organizations 2026 Genetic Engineering & Biotechnology News -New York A survey of more than 300 biopharma leaders published in August by McKinsey delivered some good news for contract development and manufacturing organizations (CDMOs): A majority said they expect to increase their reliance on CDMOs despite rising costs …
- Zealand Pharma increases its share capital as a result of the exercise of employee warrants EIN Presswire Company announcement – No. 47 / 2026 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, September 10, 2026 – Zealand Pharma A/S (“Zealand Pharma”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a …
- The Latest: Trump urges Republicans to ‘go out and vote’ on final day of midterm convention The Toronto Star Republicans have gathered in Dallas for the closing day of the party’s midterm convention that aims to highlight President Donald Trump ’s influence and boost enthusiasm among GOP voters ahead of November’s midterm election. Speakers at the two-day event …
- Can a New Weight Loss Treatment Escape the Legal and Regulatory Thicket? Reason Magazine On September 24, Eli Lilly and the Food and Drug Administration (FDA) will begin oral arguments before the 7th Circuit Court of Appeals in Eli Lilly and Company v. Robert F. Kennedy, Jr. Officially, the case is about a narrow technical question: Is Eli …
- Trump’s health picks: Who’s moving, who’s stalled Politico With help from Carmen Paun Driving the Day STATE OF PLAY — The Trump administration appears to be pushing to get a handful of its health nominees through the Senate confirmation process ahead of the midterms, though some remain in limbo. On Wednesday, the …
- The $5,000 Bribe: Trump’s Desperate Gamble and the Road to Ruin Natural News Trump's Desperate Gamble I have spent many years exposing the corruption that festers within centralized power structures, but I have never seen a scheme as transparently insulting as the $5,000 check that the current administration wants to mail to …
- FDA Halts Shipments from an Indian Plant That Supplied Sildenafil and Tadalafil to U.S. Compounding Pharmacies Medical Daily Federal inspectors documented layers of unidentified residue on production walls, floors, and equipment, corrosion on a product transfer line, and an employee working in open-toed sandals in front of open equipment at an Indian plant supplying active drug …
- Mitsotakis Touts €1bn Pharma Push at Athens Biotech Hub To Vima Μake us preferred on Google Prime Minister Kyriakos Mitsotakis toured the newly established Athens LifeTech Park in Spata, a biotechnology facility he described as offering “a glimpse of the future.” Addressing attendees, he highlighted the sector’s …
- BridgeBio Pharma: Attruby Peak Sales Set To Rise Seeking Alpha BridgeBio Pharma has delivered multiple clinical and commercial successes, yet shares have repeatedly sold off after positive catalysts. Infigratinib's dwarfism trial outperformed the market leader, and Attruby continues to beat sales estimates, with …
- Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market EIN Presswire AUSTIN, Texas, Sept. 10, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Today's multiple sclerosis treatments can slow down disease progression, but none of them halt it outright, and none give back the function patients have already lost. …
- Musings from The Power List: Ali Tavassoli The Medicine Maker What was your biggest professional highlight of the past 12 months? Being awarded the Royal Society of Chemistry's Interdisciplinary Prize, and being named on the Medicine Maker Power List 2025, was a real honor. It means a great deal for our work to …
- The Latest: Trump urges Republicans to ‘go out and vote’ on final day of midterm convention WDIV Local 4 - Michigan Republicans have gathered in Dallas for the closing day of the party’s midterm convention that aims to highlight President Donald Trump ’s influence and boost enthusiasm among GOP voters ahead of November’s midterm election. Speakers at the two-day event …
- China’s high-tech rise puts competitive pressure on Switzerland Swissinfo China’s rise is increasing competitive pressure on Switzerland Keystone-SDA Economists at Swiss bank UBS view China’s economic rise as a major challenge for the Swiss economy. The US tariffs, on the other hand, are likely to have only a temporary impact. …
- Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York EIN Presswire NEW YORK and TORONTO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs …
- Medicus Pharma Publishes Abridged Final Phase 2 SkinJect® Clinical Study Report (CSR) Results Identifying 200 µg D-MNA Patch as the Lead Development Dose EIN Presswire PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a precision guided, biotech/life sciences company focused on advancing novel and potentially disruptive therapeutic assets, today …
- HHS appoints permanent FDA CBER, CDER heads Pharmaceutical Technology The US Department of Health and Human Services (HHS) has selected four senior leaders to assume permanent positions in the US Food and Drug Administration (FDA), bringing some respite to a tumultuous period for the regulator fraught with several high- …
- Podcast: key readouts from ESC and ERS Pharmaceutical Technology It’s conference season again. In this episode, the healthcare team rounds up the latest readouts and emerging themes from two recent events: the European Society of Cardiology (ESC) Congress and the European Respiratory Society (ERS) Congress. In this …
- August biopharma layoffs impact just over 500, down 90% year over year BioSpace The biopharma layoff picture improved year over year in August, based on BioSpace tallies. The number of biotech and pharma companies cutting or projecting they’ll cut their workforces fell 48% to 12, while affected employees plunged 90% to 526. The sharp …
- Swiss pharma firm Lonza to build new factory in US Swissinfo Lonza is building a new factory in the United States Keystone-SDA Lonza is set to begin construction of a production site dedicated to spray-drying in the United States. The plant, which will be built in Bend, Oregon, is expected to be operational in 2029 …
- Weekly Basal Insulin + Semaglutide Combo May Benefit T2D Medscape The investigational once-weekly combination of semaglutide and basal insulin icodec (IcoSema, Novo Nordisk) produced greater A1c reductions and weight loss with less hypoglycemia than once-daily insulin glargine U100 in people with type 2 diabetes (T2D) …
- Multibagger stock rallies 7% after JM's 'Buy' rating; here's share price target Business Today "Electrolyte additives could address a 150,000 MTPA global market by CY30E. Acutaas has already contracted its VC/FEC capacities, which, combined with two more additives, is expected to generate Rs 400 crore in revenue by FY30E. In semiconductors …
- Endpoints News presents ‘The China biotech debate: Boston’ The Tech - Massachusetts In America’s current era of uncertain research funding, the biotechnology industry is no exception to the ambiguity. However, this domestic policy erosion is only one of two threats outlined by the American Biosecurity Initiative (ABI), an organization …
- Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update Rutland Herald - Vermont MARSEILLE, France--(BUSINESS WIRE)--Sep 10, 2026-- Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”), today announced that the Company will hold a conference call on Thursday, September 17, 2026 at 2:00 p …
- CordenPharma Boosts Aseptic Fill-Finish Capacity to 500 Million Sterile Injectable Units Per Year Devon Dispatch Breadcrumb Trail Links PR Newswire (CordenPharma Image) A graphic illustration of CordenPharma's new 11,000 m² sterile manufacturing facility in Caponago, Italy, increasing the site footprint by greater than 50%. CNW CordenPharma accelerates sterile …
- Peter Navarro claims that Sean Hannity "fought hard" to get Fox News to air Trump's address on election security Media Matters For America STEVE BANNON (HOST): You have become a centerpiece of, I think, one of the most important stories that certain news media are trying to sweep under the rug, and that is the situation with John Solomon's task force, the stolen 2020 election, President …
- Little Green Pharma (ASX:LGP): How is LGP integrating Cannatrek? Kalkine Media Highlights Little Green Pharma has a fresh disclosure linked to integration, branded access and export market execution. The Australian and European medicinal cannabis platform remain central to the operating assessment. Execution, cash discipline and …
- Can Little Green Pharma Digest Its Merger (ASX:LGP)? Kalkine Media Highlights The all-scrip combination with a Victorian cultivator was implemented mid-year, creating the largest locally listed medicinal cannabis operator by revenue. The merged group spans cultivation in Australia and Europe, certified manufacturing, …
- Innocan Pharma Announces Private Placement of Units Airdrie Echo Breadcrumb Trail Links PR Newswire Innocan Pharma Logo CNW HERZLIYA, Israel and CALGARY, Alberta, Sept. 9, 2026 /CNW/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the “Company” or “Innocan“) is pleased to announce that it …
- Why China’s rise needs to be taken with a pinch of salt Pharmaceutical Technology A closer look at the numbers that paint China as accelerating towards global biopharma dominance and you will find indications that the region’s ascension is not as unassailable as many might think. This was the message a panel of pharma representatives …
- Peter Navarro Drops Truth Bomb on Greg Kelly Show — Shares What Actually Happened on Maria Bartiromo’s Fox News Exit (VIDEO) The Gateway Pundit Screenshot White House Senior Counselor for Trade and Manufacturing Peter Navarro went on Newsmax Tuesday night and ripped the mask off Fox News. On Tuesday night, Navarro sat down with Greg Kelly on Newsmax and answered the charge that has been thrown at …